Sound businesses are the best antidote for volatility: 6 large- and mid-cap stocks with an upside potential of up to 30%The market hates uncertainty. Post the big reforms (GST and banking), the markets should have ideally been in upbeat mode this festive seas...
12 Oct, 2025, 02.28 PM IST
Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...
08 Sep, 2025, 02.45 PM IST
Suited for the long term, even with headwinds: 8 stocks from healthcare & pharma sectors with upside potential of up to 39%How to define a “defensive sector”? One where earnings increase in a secular manner and stocks have lower probability of witnessing a sharp...
11 Jul, 2025, 12.31 AM IST
One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...
03 Jul, 2025, 12.48 PM IST
Focus beyond noise and uncertainty of tariff war: 6 Large-cap stocks with an upside potential of up to 42%The coming week will see statements from different parts of the world on the tariff war unleashed by US President Trump. And these will mak...
06 Apr, 2025, 02.29 PM IST
Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...
03 Apr, 2025, 06.56 PM IST
Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the co...
22 Mar, 2025, 06.29 PM IST
Look for good quality businesses at relatively lower valuations: 5 large-caps from different sectors with upside potential of up to 44%Our headline says “relatively” lower valuations. Now, “relatively” is used in two contexts. A stock that was trading at a PE of 93 is today...
27 Feb, 2025, 08.46 PM IST
Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...
14 Jan, 2025, 02.13 PM IST
Stocks in news: Tata Motors, GMR Airports, Jubilant Industries, Cipla, Lloyd MetalsJaykay Enterprises has completed the execution of MoU with Philips Machine Tools India to synergistically expand each other's businesses on...
11 Dec, 2023, 08.27 AM IST
Cipla unit recalls one lot of medication in US due to seal integrity issueDrug major Cipla's subsidiary is voluntarily recalling one lot of medication in the US due to seal integrity issues. InvaGen Pharmaceutical...
10 Dec, 2023, 07.12 PM IST
Stocks in news: LIC, Dish TV, Adani Ports, Adani Total Gas, Tech MahindraShareholders of Dish TV India rejected appointments of four candidates as non-executive independent directors on the company board, reducin...
06 Mar, 2023, 07.07 AM IST
Stocks in the news: HDFC Bank, NMDC, Paytm, Ruchi Soya, Lupin and ICICI BankThe RBI asked Paytm Payments Bank to stop opening new accounts amid "material supervisory concerns" observed in the bank. Appointment of an...
14 Mar, 2022, 07.52 AM IST
Lupin gets USFDA nod to market generic drugThe company has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Vigabatri...
11 Mar, 2022, 08.02 PM IST
Zydus gets final US FDA nod to market generic version of Vigabatrin tabletsCadila Healthcare Ltd on Thursday said group firm Zydus has received final approval from the US health regulator to market its generic vers...
20 Jan, 2022, 11.50 AM IST
Dr Reddy's launches generic epilepsy drug in US market"We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North Ame...
02 Feb, 2021, 03.02 PM IST
Dr Reddy's launches generic oral anti-epileptic drug in USThe product is a generic version of Lundbeck's Sabril powder for oral solution, Dr Reddy's said in a filing to the BSE.
20 Aug, 2019, 06.01 PM IST